ResearcherComprehensive Cancer Center ViennaActive in the last 2 years
Gerd Jomrich
Matched on ORCID iD 0000-0002-7294-4831; OpenAlex author ID A5040384779. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2019: 1 paper · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 6
- Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal treatment. Co-author DOI 10.1016/j.jviscsurg.2023.06.004↗
- The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treatment. Co-author DOI 10.1097/sla.0000000000005874↗
- Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. Co-author DOI 10.1007/s11605-019-04187-z↗
- The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. First author DOI 10.1245/s10434-019-08161-6↗
- Correction to: The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. First author DOI 10.1245/s10434-020-09010-7↗
- Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. First author DOI 10.1371/journal.pone.0215915↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Klaus Sahora · 6 shared papers, 2019–2024 · strength 0.88
- Paper Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal tre… DOI 10.1016/j.jviscsurg.2023.06.004↗
- Paper The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treat… DOI 10.1097/sla.0000000000005874↗
- Paper The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resec… DOI 10.1245/s10434-019-08161-6↗
- Martin Schindl · 6 shared papers, 2019–2024 · strength 0.88
- Paper Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal tre… DOI 10.1016/j.jviscsurg.2023.06.004↗
- Paper The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treat… DOI 10.1097/sla.0000000000005874↗
- Paper The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resec… DOI 10.1245/s10434-019-08161-6↗
- Elisabeth S. Gruber · 5 shared papers, 2019–2024 · strength 0.70
- Paper Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal tre… DOI 10.1016/j.jviscsurg.2023.06.004↗
- Paper The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resec… DOI 10.1245/s10434-019-08161-6↗
- Paper Correction to: The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma U… DOI 10.1245/s10434-020-09010-7↗
- Michael Gnant · 4 shared papers, 2019–2020 · strength 0.51
- Paper The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resec… DOI 10.1245/s10434-019-08161-6↗
- Paper Correction to: The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma U… DOI 10.1245/s10434-020-09010-7↗
- Paper Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. DOI 10.1007/s11605-019-04187-z↗
- Gerald W. Prager · 1 shared paper, 2024 · strength 0.19
- Carlos Fernández-del Castillo · 1 shared paper, 2024 · strength 0.18
- Andrew Louis Warshaw · 1 shared paper, 2024 · strength 0.18
- Thomas P. Hank · 1 shared paper, 2024 · strength 0.18
- Ulla Klaiber · 1 shared paper, 2024 · strength 0.18
- Carl-Stephan Leonhardt · 1 shared paper, 2024 · strength 0.18
- Motaz Qadan · 1 shared paper, 2024 · strength 0.18
- Cristina Rosa Ferrone · 1 shared paper, 2024 · strength 0.18
- Oliver Strobel · 1 shared paper, 2024 · strength 0.18
- Keith D. Lillemoe · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.